(Journal Article): "Low Dose" Metformin Improves Hyperglycemia Better Than Acarbose in Type 2 Diabetics
 
Yajima K, Shimada A, Hirose H, Kasuga A, Saruta T
 
IN: Rev Diabetic Stud 2004; 1(2):89-94
Impact Factor(s) of Rev Diabetic Stud: 0.125 (2006)

ABSTRACT: OBJECTIVES: "High dose" metformin therapy (2,550 mg/day) is reported to improve glycemic control in type 2 diabetic patients with obesity (body mass index (BMI) >= 30)... Click HERE for details